Literature DB >> 11849383

Impairment of vascular regeneration precedes progressive glomerulosclerosis in anti-Thy 1 glomerulonephritis.

Yoko Wada1, Tetsuo Morioka, Yukiko Oyanagi-Tanaka, Jian Yao, Yasuhito Suzuki, Fumitake Gejyo, Masaaki Arakawa, Takashi Oite.   

Abstract

BACKGROUND: It has been proposed that glomerular hemodynamic changes or glomerular growth response may promote the development of glomerulosclerosis, irrespective of its etiology. Further experimental models are needed to clarify the cellular and molecular mechanisms that lead to progressive glomerulosclerosis with an irreversible course. We designed a model of irreversible glomerulosclerosis, using anti-Thy-1.1 injection followed by uninephrectomy, and examined the role of glomerular endothelial cell responses in the process of progressive sclerotic changes.
METHOD: Rats were injected with anti-Thy-1.1 monoclonal antibody, 1-22-3, and 30 minutes later, unilateral nephrectomy (one-kidney group) or sham operation (two-kidney group) was performed. Rats were sacrificed for histological examination on days 3, 14, 56, and 84 after injection. The density of the glomerular capillary tuft was assessed by immunofluorescent staining for endothelial specific antigens. The mRNA expression of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), platelet-endothelial cell adhesion molecule-1 (PECAM-1), and vascular endothelial growth factor (VEGF) also was followed up by reverse transcription-polymerase chain reaction (RT-PCR).
RESULTS: Semiquantitative analysis revealed that the capillary density and mRNA expression of PECAM-1, VCAM-1 and VEGF were significantly lower in the one-kidney group compared to the two-kidney group on day 14. On day 84, progressive glomerulosclerotic lesions were found, followed by a decrease of the capillary density in the one-kidney group, while the glomerular architecture recovered to an almost normal state in the two-kidney group.
CONCLUSIONS: Progressive glomerulosclerosis can be induced in the rat by a one shot injection of anti-Thy 1.1 monoclonal antibody followed by unilateral nephrectomy. This model shows that there is a positive association between impairment of vascular regeneration and the development of glomerulosclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849383     DOI: 10.1046/j.1523-1755.2002.00137.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  The effect of renal administration of a selective cyclooxygenase-2 inhibitor or stable prostaglandin I2 analog on the progression of sclerotic glomerulonephritis in rats.

Authors:  Yukiko Nozawa; Ayako Sato; Hoglan Piao; Tetsuo Morioka; Ichiei Narita; Takashi Oite
Journal:  Clin Exp Nephrol       Date:  2011-12-07       Impact factor: 2.801

2.  Models of chronic kidney disease.

Authors:  Hai-Chun Yang; Yiqin Zuo; Agnes B Fogo
Journal:  Drug Discov Today Dis Models       Date:  2010

3.  VEGF ameliorates tubulointerstitial fibrosis in unilateral ureteral obstruction mice via inhibition of epithelial-mesenchymal transition.

Authors:  Yao-guo Lian; Qiu-gen Zhou; Ying-juan Zhang; Fa-lei Zheng
Journal:  Acta Pharmacol Sin       Date:  2011-10-10       Impact factor: 6.150

Review 4.  Chronic kidney disease-associated cardiovascular disease: scope and limitations of animal models.

Authors:  Omid Sadeghi-Alavijeh; Mohammad Tadayyon; Ben Caplin
Journal:  Cardiovasc Endocrinol       Date:  2017-11-15

5.  Analysis of glomerular VEGF mRNA and protein expression in murine mesangioproliferative glomerulonephritis.

Authors:  Christian S Haas; Valentina Câmpean; Alexander Kuhlmann; Arno Dimmler; Udo Reulbach; Christian Forster; Thomas Aigner; Till Acker; Karl Plate; Kerstin Amann
Journal:  Virchows Arch       Date:  2006-11-22       Impact factor: 4.064

6.  Local delivery of a direct renin inhibitor into the kidney ameliorates progression of experimental glomerulonephritis.

Authors:  Ayako Sato; Hoglan Piao; Yukiko Nozawa; Tetsuo Morioka; Hiroshi Kawachi; Takashi Oite
Journal:  Clin Exp Nephrol       Date:  2012-02-11       Impact factor: 2.801

7.  What is the significance of CD34 immunostaining in the extraglomerular and intraglomerular mesangium?

Authors:  Cristina Gluhovschi; Gheorghe Gluhovschi; Elena Potencz; Diana Herman; Ligia Petrica; Silvia Velciov; Gheorghe Bozdog; Flaviu Bob; Corina Vernic; Daniel Cioca
Journal:  Virchows Arch       Date:  2008-08-08       Impact factor: 4.064

8.  Glomerular expression of connexin 40 and connexin 43 in rat experimental glomerulonephritis.

Authors:  Tetsuo Morioka; Shinichi Okada; Masaaki Nameta; Fadia Kamal; Nadia T Yanakieva-Georgieva; Jian Yao; Ayako Sato; Honglan Piao; Takashi Oite
Journal:  Clin Exp Nephrol       Date:  2012-09-04       Impact factor: 2.801

9.  ACE Inhibition in Anti-Thy1 Glomerulonephritis Limits Proteinuria but Does Not Improve Renal Function and Structural Remodeling.

Authors:  Peter E Westerweel; Jaap A Joles; Krista den Ouden; Roel Goldschmeding; Maarten B Rookmaaker; Marianne C Verhaar
Journal:  Nephron Extra       Date:  2012-01-26

Review 10.  Exploring the mechanisms of renoprotection against progressive glomerulosclerosis.

Authors:  Takashi Oite
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.